Table 2

Data relating to infusions of DrotAA

Infusion-related data
All admissions receiving DrotAA (n = 1,292)

Time from unit admission to start of infusion (hours; median [IQR])
19.5 (9.3–35.3)
Received complete 96-hour infusion (n [%])
896 (69.9)
Reason for not receiving complete infusion (n [%])
     Deterioration/treatment withdrawn/died
195 (50.8)
     Actual/possible bleeding
91 (23.7)
     Patient improved/left ward
34 (8.9)
     Other intervention/treatment outside unit
16 (4.2)
     Criteria reassessed/incorrect
9 (2.3)
     Timing error
8 (2.1)
     Other intervention/treatment in unit
5 (1.3)
     Macro/micro drug supply issues
4 (1.0)
     Infused over shorter time period
1 (0.3)
     No reason given/not known
21 (5.5)
Interruption in the infusion (n [%])
304 (24.0)
Time from start of infusion to interruption (hours; median [IQR])
24.0 (13.2–49.0)
Duration of interruption (hours; median [IQR])
5 (3–10)
Reason for interruption (n [%])
     Lines/catheters/cannula/drain/dressing-inserted/changed/removed/re-sited/fell out
144 (48.0)
     To theatre
48 (16.0)
     Bleeding related (actual/suspected)
35 (11.7)
     Intervention off unit
15 (5.0)
     Tracheostomy
15 (5.0)
     Intervention on unit
11 (3.7)
     In error
10 (3.3)
     Macro/micro drug supply issues
10 (3.3)
     Patients condition improved/left unit
1 (0.3)
     No reason given/not known
11 (3.7)

IQR, interquartile range.

Rowan et al. Critical Care 2008 12:R58   doi:10.1186/cc6879